Source:http://linkedlifedata.com/resource/pubmed/id/18173757
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2008-1-4
|
pubmed:abstractText |
Cushing syndrome (CS) features high-glucocorticoid secretion and an associated hypercoagulable state often involving an increase in von Willebrand factor (VWF). To identify any influence of VWF promoter on glucocorticoid haemostatic effects, four polymorphic positions (-3267, -2708, -2659 and -2525) segregating as haplotypes 1 (GCAG) or 2 (CTGA) were analysed in 50 CS patients with high VWF (group I) and normal VWF (group II) levels, divided by ABO group. Genotype distribution differed significantly between the two groups: in group I, 25.8% had genotype 1/1, 22.6% had 2/2 and 38.7% had 1/2; in group II, 0% had genotype 1/1, 57.9% had 2/2 and 31.6% had 1/2 (P = 0.03). Patients' genotypes also differed from those of controls (P = 0.003 for group I, P = 0.03 for group II). Haplotype 1 was prevalent in group I, haplotype 2 in group II (P = 0.002), both with frequencies differing from controls (P < 0.001 and P = 0.009). By odds ratio analysis, genotype 1/1 carried a 12 times greater risk of high-VWF levels than genotype 2/2, and haplotype 1 carried a five times greater risk than haplotype 2. Our findings suggest that VWF promoter haplotypes influence the corticosteroid-mediated increase in VWF.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1365-2141
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
140
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
230-5
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:18173757-Adult,
pubmed-meshheading:18173757-Cushing Syndrome,
pubmed-meshheading:18173757-Female,
pubmed-meshheading:18173757-Gene Frequency,
pubmed-meshheading:18173757-Glucocorticoids,
pubmed-meshheading:18173757-Haplotypes,
pubmed-meshheading:18173757-Hemostasis,
pubmed-meshheading:18173757-Humans,
pubmed-meshheading:18173757-Hydrocortisone,
pubmed-meshheading:18173757-Male,
pubmed-meshheading:18173757-Middle Aged,
pubmed-meshheading:18173757-Polymorphism, Single Nucleotide,
pubmed-meshheading:18173757-Promoter Regions, Genetic,
pubmed-meshheading:18173757-von Willebrand Factor
|
pubmed:year |
2008
|
pubmed:articleTitle |
Polymorphisms in von Willebrand factor gene promoter influence the glucocorticoid-induced increase in von Willebrand factor: the lesson learned from Cushing syndrome.
|
pubmed:affiliation |
Department of Medical and Surgical Sciences, Second Chair of Internal Medicine, University of Padua Medical School, Padua, Italy. sandra.casonato@unipd.it
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|